Flavonoids hesperidin and hesperetin inhibited the activities of two gluconeogenesis enzymes, alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indicating their effectiveness in treating AST and ALT-mediated metabolic disorders, including in diabetes mellitus. The gene discussed is GPT; the disease is metabolic disease.